‘Corrigendum to “Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells” [Biomed. Pharmacother. 98 (2018) 36–44]’
Main Authors: | Yuwan Zhao, Huancheng Tang, Xin Zeng, Dongcai Ye, Jianjun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222007181 |
Similar Items
-
Corrigendum to “Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis” [Biomed. Pharmacother. 98 (2018) 382–389]
by: Ya-Min Tang, et al.
Published: (2023-11-01) -
Retraction notice to 'Potential role of andrographolide in the proliferation of osteoblasts mediated by the ERK signaling pathway' [Biomed. Pharmacother. 83 (2016) 1335–1344]
by: Bo Li, et al.
Published: (2023-07-01) -
Corrigendum to “MiR-337-3p promotes chondrocytes proliferation and inhibits apoptosis by regulating PTEN/AKT axis in osteoarthritis” [Biomed. Pharmacother. 95 (2017) 1194–1200]
by: Zhihui Huang, et al.
Published: (2022-09-01) -
Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01) -
Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)